| |
| |
|
| Insider
Information: |
Caforio Giovanni |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
435,474 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,519,094 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
435,474 |
|
|
| Total
Value |
$20,519,094 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
| Percentage
Gain/Loss : |
0.0%
|
 1.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
Executive Chair of the... |
2024-03-10 |
432,266 |
|
0 |
Premium* |
|
|
Stryker Corp |
SYK |
Director |
2024-05-09 |
3,208 |
2023-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
Pres., US PharmaceuticalsOffic |
• – – |
2011-10-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
38,818 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2016-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(110) |
93,509 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
384 |
45,527 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
404 |
44,636 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-03-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
420 |
581,104 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2023-10-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
440 |
367,495 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-03-04 |
4 |
D |
$32.59 |
$17,990 |
D/D |
(552) |
47,095 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-03-02 |
4 |
D |
$32.59 |
$18,739 |
D/D |
(575) |
44,952 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
652 |
135,201 |
0 |
- |
|
| SYK |
Stryker Corp |
Director |
– • – |
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
653 |
3,208 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-03-03 |
4 |
D |
$32.59 |
$21,933 |
D/D |
(673) |
46,130 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-03-01 |
4 |
D |
$32.64 |
$22,522 |
D/D |
(690) |
43,946 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• • – |
2013-03-03 |
4 |
D |
$37.15 |
$25,634 |
D/D |
(690) |
53,011 |
0 |
- |
|
| SYK |
Stryker Corp |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
705 |
2,555 |
0 |
- |
|
| SYK |
Stryker Corp |
Director |
– • – |
2023-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
841 |
1,850 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Operating Officer |
• • – |
2015-03-02 |
4 |
D |
$62.30 |
$69,402 |
D/D |
(1,114) |
47,273 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,190) |
409,368 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,197 |
45,143 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2017-05-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,384) |
179,074 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,493 |
44,232 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Operating Officer |
• • – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,494 |
46,893 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Operating Officer |
• • – |
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,494 |
48,387 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,517 |
47,647 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2021-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,635) |
473,453 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2018-05-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,643) |
291,179 |
0 |
- |
|
119 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
